Skip to main content

Screening and Risk Reduction Strategies for Breast Cancer

Imaging Modality and Risk-Reduction Approaches

  • Book
  • © 2023


  • Touch upon current topics in breast cancer screening
  • More individualized screening system for breast cancers are focused upon
  • Possible understand background and advances on the risk reduction of breast cancers

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

About this book

This book provides readers with the most up-to-date practical information on breast cancer screening. Since breast cancers are highly heterogeneous, time to clinical onset from the initial carcinogenesis differs diversely between cancers. Pathological germline variants and driver mutations cause a high lifetime risk of breast cancer. The lifetime risks are various according to what genes are pathologically dysfunctional. Integrated omics and imaging technologies have established varying tumour characteristics. Thus, this book suggests that a more individualised scheme is required to improve breast cancer screening.

A key aim is to demonstrate how multiple diagnostic imaging modalities such as mammography, ultrasonography, MRI, PET and dbPET improve breast cancer screening accuracy. Mammography screening alone may have a limited impact on breast cancer risk prediction. These issues are crucial to discuss. Clinical experts recommend that new modalities be incorporated for women with dense breasts, like ultrasonography, dynamic mammography, MRI and maybe breast-dedicated PET. Topics on these modalities are going to be summarized in this book.  An in-depth review of these modalities is summarised in this book. In addition, new diagnostic modalities, including risk assessment tools, multi-cancer early detection tests using liquid biopsy, the role of protein biomarkers in breast cancer risk screening, challenges, and hopes for future advances, are also covered in this book.

Similar content being viewed by others


Table of contents (14 chapters)

Editors and Affiliations

  • Grad. School Medicine, Surgery, Kyoto University, Kyoto, Japan

    Masakazu Toi

About the editor

Masakazu Toi, Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Bibliographic Information

  • Book Title: Screening and Risk Reduction Strategies for Breast Cancer

  • Book Subtitle: Imaging Modality and Risk-Reduction Approaches

  • Editors: Masakazu Toi

  • DOI:

  • Publisher: Springer Singapore

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2023

  • Hardcover ISBN: 978-981-19-7629-2Published: 02 March 2023

  • Softcover ISBN: 978-981-19-7632-2Published: 03 March 2024

  • eBook ISBN: 978-981-19-7630-8Published: 01 March 2023

  • Edition Number: 1

  • Number of Pages: XII, 189

  • Number of Illustrations: 11 b/w illustrations, 31 illustrations in colour

  • Topics: Medical and Radiation Physics, Surgery, Medicine/Public Health, general

Publish with us